SCHEMBL6800296

SCHEMBL6800296

CON(C)C(=O)c1c(C)coc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
KDM4E B2RXH2 7/20 0.40
HPGD P15428 7/20 0.40
POLB P06746 2/20 0.40
PTGS1 P23219 1/20 0.37
MAPT P10636 1/20 0.36
HSD17B10 Q99714 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
MLYCD O95822 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.34
NR4A2 P43354 1/20 0.33
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809056 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDPOLBPTGS1
SCHEMBL6804005 0.77 KDM4E (0.44) ALDH1A1KDM4EHPGDPOLBPTGS1
SCHEMBL13228953 0.73 KMT2A (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2MLYCD
SCHEMBL4449884 0.72 MAPT (0.56) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL28777 0.70 MLYCD (0.54) ALDH1A1KDM4EHPGDNPC1MLYCD
SCHEMBL18069275 0.70 OXTR (0.49) SMN1; SMN2MLYCDMEN1KMT2A
Hydrochloric Acid SCHEMBL7476159 0.69 MLYCD (0.53) ALDH1A1KDM4EHPGDNPC1MLYCD
SCHEMBL15909612 0.69 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL772236 0.68 KMO (0.53) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL2837585 0.68 KMT2A (0.50) ALDH1A1MAPTSMN1; SMN2NPC1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142976-A1 Pyridylfuran and pyridylthiophene compounds PFIZER INC. 2004-07-22 US disclosed
US-6696470-B2 FOR THERAPY OF ARTHRITIS, ASTHMA, BONE RESORPTION DISEASE, CACHEXIA, CARDIOVASCULAR DISEASE, CEREBRAL MALARIA, CROHN'S DISEASE, DIABETES, FEVER OR MYALGIA DUE TO INFECTION, GOUT, GRAFT VERSUS HOST REACTION, INFLAMMATION OF ORGANS, ETC. PFIZER INC. 2004-02-24 US disclosed
US-20020022729-A1 Pyridylfuran and pyridylthiophene compounds KAWAI AKIYOSHI (JP) 2002-02-21 US disclosed
EP-0853083-B1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof PFIZER (US) 2001-09-12 EP disclosed
US-6048880-A THERAPY FOR CYTOKINE SENSITIVE DISEASES PFIZER PHARAMACEUTICALS INC. (JP) 2000-04-11 US disclosed
EP-0853083-A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof PFIZER INC. (US) 1998-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142976-A1 Pyridylfuran and pyridylthiophene compounds MC2R, FCGR2A, OGFR ALDH1A1 789/4885KDM4E 4616/4885HPGD 1176/4885
US-20020022729-A1 Pyridylfuran and pyridylthiophene compounds MC2R, CRHR1, NR3C2 ALDH1A1 729/4885KDM4E 4610/4885HPGD 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.